Age: 67.0
Sex: F
Vaccine: COVID19-2
Symptoms: Expired product administered, No adverse event
Clinical narrative: No adverse event; a vaccine was inadvertently administered past the expiry date/The vial expired on 18-Jun-2023 and was administer on 20-Jun-2023; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (a vaccine was inadvertently administered past the expiry date/The vial expired on 18-Jun-2023 and was administer on 20-Jun-2023) and NO ADVERSE EVENT (No adverse event) in a 67-year-old female patient who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. 069H22A) for COVID-19 prophylaxis.     The patient had not reported any relevant medical history/conditions, allergy, concomitant diseases and risk factor (including any previous COVID-19 diagnosis).  It was reported that the patient did not have any reaction of her covid vaccine.  Previously administered products included for Product used for unknown indication: COVID-19 VACCINE JANSSEN (lot number 043A21A) on 09-Apr-2021, COVID-19 VACCINE JANSSEN (lot number 213D21A) on 12-Nov-2021, PFIZER BIONTECH COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/5) (lot number GH9702 and bivalent booster) on 20-Sep-2022. Past adverse reactions to the above products included No adverse event with COVID-19 VACCINE JANSSEN, COVID-19 VACCINE JANSSEN, PFIZER BIONTECH COVID-19 VACCINE and BIVALENT (ORIGINAL AND OMICRON BA.4/5).    On 20-Jun-2023, the patient received fourth dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) .5 milliliter. On 20-Jun-2023,  after starting mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)), the patient experienced EXPIRED PRODUCT ADMINISTERED (a vaccine was inadvertently administered past the expiry date/The vial expired on 18-Jun-2023 and was administer on 20-Jun-2023). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (a vaccine was inadvertently administered past the expiry date/The vial expired on 18-Jun-2023 and was administer on 20-Jun-2023) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for EXPIRED PRODUCT ADMINISTERED (a vaccine was inadvertently administered past the expiry date/The vial expired on 18-Jun-2023 and was administer on 20-Jun-2023).    The patient did not receive any other vaccines in the 4 weeks prior to COVID-19 vaccine. No concomitant medication was reported. The department of Health informed that a few lot numbers had an extension from September to October. Since one of the lot numbers that was extended had a very similar number and letter to the one that was not extended. The vaccine was inadvertently administered a vial past expiration. The expiry date was reported as 18-Jun-2023. No PQC was reported. No treatment medication was reported.